Cowen Washington Research Group compliance disclosures for cannabis‑related stocks

Cowen Washington Research Group compliance disclosures for cannabis‑related stocks The document is a routine regulatory disclosure describing Cowell's own conflicts‑of‑interest policies, market‑making activities, and past investment‑banking services for several cannabis‑sector companies. It contains no specific allegations, financial flow details, or connections to high‑level officials, making it low‑value for investigative leads. Key insights: Cowen acted as market maker and placement agent for GW Pharmaceuticals, Tilray, Turning Point Brands, and Canopy Growth.; Cowen provided investment‑banking services and expects future compensation from Tilray and Turning Point Brands.; The report includes standard analyst certification and conflict‑of‑interest language required by FINRA.